American Journal of Epidemiology Advance Access originally published online on April 12, 2006
American Journal of Epidemiology 2006 164(1):41-46; doi:10.1093/aje/kwj151
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contribution |
Association of Anthropometric Measures with the Presence and Progression of Benign Prostatic Hyperplasia
1 Division of Epidemiology, Mayo Clinic, Rochester, MN
2 Department of Epidemiology, Merck Research Laboratories, West Point, PA
3 Division of Biostatistics, Mayo Clinic, Rochester, MN
4 Department of Medicine, Mayo Clinic, Rochester, MN
5 Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA
Correspondence to Dr. Steven J. Jacobsen, Department of Research and Evaluation, Southern California Permanente Medical Group, Second Floor, 100 South Los Robles Avenue, Pasadena, CA 91101 (e-mail: steven.j.jacobsen{at}kp.org).
The authors investigated the association of anthropometric measures with the presence and progression of components of benign prostatic hyperplasia (BPH) and a clinical outcome of BPH in a cohort of healthy, Caucasian men aged 4079 years that was randomly selected from the Olmsted County, Minnesota, population beginning in 1990. Exclusionary criteria included prostate or bladder surgery, urethral surgery or stricture, or medical or other neurologic conditions that could affect normal urinary function. Height, weight, and waist and hip circumferences were measured. Components of BPH, including American Urological Association Symptom Index scores, peak urinary flow rate, and prostate volume, were assessed on a randomly selected subsample. Acute urinary retention was assessed through review of community medical records. There were few significant associations of anthropometric measures with the presence or progression of components of BPH or clinical outcome of BPH, and there were no instances where the point estimates for the BPH components suggested a dose-response effect. The authors conclude that anthropometric measures are not significantly associated with the presence or progression of BPH as measured by American Urological Association Symptom Index scores, peak urinary flow rate, prostate volume, or acute urinary retention. These data provide no evidence of a consistent significant relation between anthropometric measures and BPH.
anthropometry; prostatic hyperplasia; urinary retention
Abbreviations: AUASI, American Urological Association Symptom Index; BPH, benign prostatic hyperplasia; Pvol, prostate volume; Qmax, peak urinary flow rate
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Gerber, S. J. Jacobsen, J. M. Killian, S. A. Weston, and V. L. Roger Participation Bias Assessment in a Community-Based Study of Myocardial Infarction, 2002-2005 Mayo Clin. Proc., August 1, 2007; 82(8): 933 - 938. [Abstract] [Full Text] [PDF] |
||||
